Complete Filing Data
Blackstone Secured Lending Fund reported Stock Issued During Period Value Dividend Reinvestment Plan of $23.04 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Blackstone Secured Lending Fund did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $5.0M | $3.6M | $6.1M | $6.3M | $4.8M | $4.2M |
| Net Income Loss | $563.5M | $694.1M | $612.0M | $404.6M | $460.4M | $218.6M |
| Interest Expense | $381.6M | $326.1M | $266.4M | $203.6M | $120.5M | $65.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $1.5M | $1.2M | $1.1M | $740.0K | $985.0K | $1.2M | $2.1M | $2.0M | $1.6M | $1.6M | $1.6M | $1.3M | $1.7M |
| Net Income Loss | $132.4M | $155.0M | $149.8M | $151.7M | $196.2M | $183.8M | $171.0M | $144.9M | $138.8M | $95.9M | $79.6M | $107.2M | $110.0M |
| Interest Expense | $94.7M | $92.3M | $93.0M | $88.2M | $78.8M | $66.7M | $65.3M | $66.1M | $66.7M | $55.3M | $45.1M | $40.3M | $32.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.25B | $6.08B | $4.95B | $4.16B | $4.45B | $3.27B | $1.67B | $236.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $289.6M | $229.6M | $154.9M | $131.3M | $102.9M | $218.0M | $65.5M | |
| Amortization Of Debt Issuance Costs Line Of Credit Arrangements | $5.7M | $6.1M | $5.5M | $4.0M | $2.7M | $3.8M | ||
| Debt And Equity Securities Realized Gain Loss | $10.0K | -$19.0M | -$6.2M | $37.4M | $7.8M | -$4.4M | ||
| Repayments Of Debt | $1.92B | $1.45B | $2.09B | $877.2M | $2.78B | $1.95B | ||
| Debt And Equity Securities Unrealized Gain Loss | -$149.1M | -$14.2M | -$50.8M | -$126.5M | $104.7M | -$16.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $72.0M | $75.8M | $26.7M | $24.8M | -$115.1M | $152.5M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $53.4M | $39.9M | $52.9M | $47.4M | $62.8M | $50.1M | ||
| Retained Earnings Accumulated Deficit | $197.2M | $326.5M | $250.0M | $125.7M | $199.9M | |||
| Receivable Investment Sale | $3.2M | $3.0M | $1.3M | $49.3M | $142.9M | |||
| Payable Investment Purchase | $2.2M | $19.3M | $8.6M | $20.3M | $36.2M | |||
| Management Fee Payable | $36.1M | $32.3M | $23.0M | $18.6M | $17.8M | |||
| Long Term Debt | $8.08B | $7.06B | $4.91B | $5.53B | $5.50B | |||
| Liabilities And Stockholders Equity | $14.66B | $13.47B | $10.13B | $9.91B | $10.18B | |||
| Liabilities | $8.41B | $7.40B | $5.18B | $5.75B | $5.73B | |||
| Investment Owned Percent Of Net Assets | $2.28 | $2.16 | $1.99 | $2.31 | $2.22 | |||
| Interest Payable Current And Noncurrent | $62.0M | $54.0M | $39.9M | $45.3M | $39.1M | |||
| Distribution Payable | $178.6M | $170.8M | $143.1M | $96.2M | $89.7M | |||
| Deferred Finance Costs Net | $39.9M | $34.9M | $26.0M | $35.3M | $45.7M | |||
| Debt Issuance Costs Line Of Credit Arrangements Net | $19.8M | $21.9M | $16.5M | $13.3M | $13.6M | |||
| Common Stock Value | $232.0K | $222.0K | $186.0K | $160.0K | $169.0K | |||
| Cash And Cash Equivalents At Carrying Value | $289.6M | $229.6M | $154.9M | $131.3M | $102.9M | |||
| Assets | $14.66B | $13.47B | $10.13B | $9.91B | $10.18B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.27B | $6.29B | $6.24B | $5.70B | $5.39B | $5.16B | $4.60B | $4.35B | $4.19B | $4.17B | $4.36B | $4.43B | $4.14B | $3.74B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $249.9M | $273.7M | $965.0M | $194.2M | $291.3M | $147.7M | $145.8M | $147.4M | $103.0M | $131.2M | $168.6M | $140.9M | $259.6M | |
| Amortization Of Debt Issuance Costs Line Of Credit Arrangements | $1.4M | $1.4M | $1.4M | $1.4M | $1.7M | $1.7M | $1.4M | $1.3M | $1.1M | $839.0K | ||||
| Debt And Equity Securities Realized Gain Loss | $8.5M | $428.0K | -$3.5M | $31.2M | $5.4M | -$1.8M | ||||||||
| Repayments Of Debt | $559.6M | $0.00 | $176.7M | $69.0K | ||||||||||
| Debt And Equity Securities Unrealized Gain Loss | -$40.8M | $11.8M | -$11.4M | -$2.1M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $734.8M | -$7.2M | -$30.9M | $38.1M | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $16.4M | $9.7M | $9.1M | $10.6M | ||||||||||
| Retained Earnings Accumulated Deficit | $233.6M | $279.0M | $300.9M | $320.3M | $329.5M | $286.0M | $218.6M | $181.2M | $152.1M | $99.4M | ||||
| Receivable Investment Sale | $17.2M | $23.4M | $8.4M | $54.6M | $52.7M | $14.0K | $60.7M | $45.3M | $26.7M | $40.0M | ||||
| Payable Investment Purchase | $5.7M | $2.3M | $27.5M | $5.0M | $6.4M | $19.3M | $11.0M | $19.5M | $6.9M | $18.8M | ||||
| Management Fee Payable | $35.0M | $34.6M | $34.3M | $30.2M | $28.1M | $26.0M | $18.2M | $18.2M | $18.5M | $19.0M | ||||
| Long Term Debt | $7.66B | $7.09B | $7.38B | $6.39B | $6.08B | $5.27B | $4.96B | $4.98B | $5.45B | $5.51B | ||||
| Liabilities And Stockholders Equity | $14.26B | $13.71B | $13.97B | $12.37B | $11.77B | $10.71B | $9.80B | $9.57B | $9.85B | $9.93B | ||||
| Liabilities | $7.99B | $7.42B | $7.73B | $6.67B | $6.38B | $5.55B | $5.20B | $5.22B | $5.66B | $5.76B | ||||
| Investment Owned Percent Of Net Assets | $2.20 | $2.11 | $2.06 | $2.10 | $2.09 | $2.02 | $2.06 | $2.14 | $2.30 | $2.32 | ||||
| Interest Payable Current And Noncurrent | $58.4M | $65.2M | $57.9M | $23.9M | $44.3M | $30.1M | $27.2M | $45.3M | $20.2M | $19.7M | ||||
| Distribution Payable | $177.8M | $177.0M | $175.4M | $160.9M | $152.7M | $147.7M | $133.6M | $115.8M | $112.4M | $130.0M | ||||
| Deferred Finance Costs Net | $35.0M | $38.9M | $42.7M | $26.3M | $28.9M | $23.9M | $28.0M | $30.2M | $32.7M | $37.9M | ||||
| Debt Issuance Costs Line Of Credit Arrangements Net | $21.2M | $19.5M | $20.5M | $16.1M | $13.0M | $14.8M | $14.6M | $16.0M | $14.6M | $14.5M | ||||
| Common Stock Value | $231.0K | $230.0K | $228.0K | $209.0K | $198.0K | $192.0K | $173.0K | $165.0K | $162.0K | $162.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $249.9M | $273.7M | $965.0M | $194.2M | $291.3M | $147.7M | $145.8M | $147.4M | $103.0M | $131.2M | ||||
| Assets | $14.26B | $13.71B | $13.97B | $12.37B | $11.77B | $10.71B | $9.80B | $9.57B | $9.85B | $9.93B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $2.84B | $3.62B | $1.44B | $920.8M | $5.78B | $2.99B |
| Proceeds From Disposition Of Investment Operating Activity | $2.23B | $787.5M | $1.31B | $1.17B | $2.73B | $2.03B |
| Payments Of Dividends | $678.0M | $583.4M | $438.0M | $423.4M | $253.8M | $145.1M |
| Payments For Purchase Of Investment Operating Activity | $3.27B | $3.94B | $1.48B | $961.8M | $6.82B | $4.49B |
| Net Cash Provided By Used In Operating Activities | -$458.7M | -$2.53B | $458.8M | $672.9M | -$3.83B | -$2.32B |
| Net Cash Provided By Used In Financing Activities | $530.6M | $2.60B | -$432.2M | -$648.2M | $3.71B | $2.47B |
| Increase Decrease In Management Fee Payable | $3.8M | $9.3M | $4.4M | $783.0K | $7.5M | $5.2M |
| Increase Decrease In Interest Payable Net | $8.0M | $14.1M | -$5.4M | $6.1M | $24.4M | $9.2M |
| Increase Decrease In Due To Affiliates | -$2.3M | -$1.8M | -$1.9M | $4.2M | $1.3M | $3.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $3.6M | $4.7M | $12.0M | -$2.2M | $2.5M | -$217.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$12.0M | -$1.1M | -$3.1M | $3.6M | $0.00 | $0.00 |
| Proceeds From Issuance Of Common Stock | $295.4M | $1.04B | $665.3M | $0.00 | $981.1M | $1.58B |
| Payments Of Debt Issuance Costs Line Of Credit Arrangements | $3.6M | $11.5M | $8.6M | $3.8M | $9.4M | $6.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $846.9M | $363.8M | $84.0M | $136.9M |
| Proceeds From Disposition Of Investment Operating Activity | $978.0M | $186.7M | $109.1M | $133.1M |
| Payments Of Dividends | $165.6M | $137.4M | $91.8M | $78.2M |
| Payments For Purchase Of Investment Operating Activity | $689.2M | $719.1M | $102.3M | $277.7M |
| Net Cash Provided By Used In Operating Activities | $424.7M | -$395.5M | $155.9M | -$19.2M |
| Net Cash Provided By Used In Financing Activities | $310.1M | $388.3M | -$186.8M | $57.2M |
| Increase Decrease In Management Fee Payable | $2.0M | $3.0M | -$73.0K | $1.4M |
| Increase Decrease In Interest Payable Net | $4.0M | -$9.8M | -$25.1M | -$24.7M |
| Increase Decrease In Due To Affiliates | -$89.0K | -$169.0K | $3.0M | -$342.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$9.2M | -$8.5M | $3.0M | -$2.7M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $615.0K | -$20.0K | $2.7M | $0.00 |
| Proceeds From Issuance Of Common Stock | $189.2M | $162.0M | $0.00 | |
| Payments Of Debt Issuance Costs Line Of Credit Arrangements | $0.00 | $2.4M | $400.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $26.92 | $27.39 | $26.66 | $25.93 | $26.27 | $25.20 | $26.02 | $24.57 | $25.00 |
| Investment Company Investment Income Loss Per Share | $3.23 | $3.51 | $3.90 | $2.91 | $2.43 | $2.51 | $2.18 | $0.17 | |
| Common Stock Shares Outstanding | 232.0M | 221.9M | 185.8M | 160.4M | 169.3M | 129.7M | 64.3M | 9.6M | |
| Weighted Average Number Of Shares Outstanding Basic | 229.2M | 201.4M | 167.6M | 166.1M | 144.5M | 95.3M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 229.2M | 201.4M | 167.6M | 166.1M | 144.5M | 95.3M | |||
| Earnings Per Share Diluted | $2.46 | $3.45 | $3.65 | $2.44 | $3.19 | $2.29 | |||
| Earnings Per Share Basic | $2.46 | $3.45 | $3.65 | $2.44 | $3.19 | $2.29 | |||
| Common Stock Shares Issued | 232.0M | 221.9M | 185.8M | 160.4M | 169.3M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $26.15 | ||||||||||||
| Investment Company Investment Income Loss Per Share | $0.82 | $0.77 | $0.83 | $0.91 | $0.89 | $0.87 | $0.95 | $1.06 | $0.93 | $0.80 | $0.62 | $0.61 | $0.63 |
| Common Stock Shares Outstanding | 231.0M | 230.1M | 227.8M | 209.0M | 198.4M | 191.9M | 173.4M | 165.4M | 160.6M | 161.8M | 168.2M | 169.7M | 158.4M |
| Weighted Average Number Of Shares Outstanding Basic | 230.5M | 228.2M | 226.6M | 203.4M | 193.9M | 190.6M | 169.8M | 161.1M | 160.5M | 165.0M | 169.4M | 169.6M | 147.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 230.5M | 228.2M | 226.6M | 203.4M | 193.9M | 190.6M | 169.8M | 161.1M | 160.5M | 165.0M | 169.4M | 169.6M | 147.9M |
| Earnings Per Share Diluted | $0.57 | $0.68 | $0.66 | $0.75 | $1.01 | $0.96 | $1.01 | $0.90 | $0.86 | $0.58 | $0.47 | $0.63 | $0.74 |
| Earnings Per Share Basic | $0.57 | $0.68 | $0.66 | $0.75 | $1.01 | $0.96 | $1.01 | $0.90 | $0.86 | $0.58 | $0.47 | $0.63 | $0.74 |
| Common Stock Shares Issued | 231.0M | 230.1M | 227.8M | 209.0M | 198.4M | 191.9M | 173.4M | 165.4M | 160.6M | 161.8M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $23.0M | $21.1M | $20.7M | $52.4M | $38.9M | $18.7M |
| Trustee Fees | $1.2M | $1.1M | $907.0K | $853.0K | $571.0K | $467.0K |
| Professional Fees | $4.9M | $4.7M | $6.1M | $4.0M | $2.9M | $2.0M |
| Net Investment Income | $756.0M | $722.1M | $670.7M | $485.2M | $354.1M | $240.1M |
| Management Fee Expense | $140.0M | $116.6M | $98.1M | $101.7M | $62.4M | $32.9M |
| Investment Income Operating Tax Expense Benefit | $16.1M | $14.5M | $16.8M | $1.4M | $2.4M | $517.0K |
| Investment Income Operating After Expense And Tax | $739.9M | $707.6M | $653.9M | $483.8M | $351.7M | $239.6M |
| Investment Income Investment Expense | $662.9M | $604.8M | $508.6M | $404.4M | $277.1M | $148.1M |
| Investment Company Dividend Distribution | $708.9M | $632.1M | $504.8M | $482.4M | $295.8M | $222.7M |
| Gross Investment Income Operating | $1.42B | $1.33B | $1.14B | $850.3M | $624.7M | $389.6M |
| Administrative Fees Expense | $3.5M | $2.6M | $2.3M | $2.7M | $2.4M | $2.3M |
| Interest Paid Net | $353.5M | $297.5M | $256.5M | $182.2M | $94.6M | $51.9M |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$153.7M | -$13.5M | -$54.6M | -$122.1M | $104.2M | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$22.8M | -$13.0K | $12.6M | $42.9M | $4.6M | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$176.5M | -$13.5M | -$42.0M | -$79.2M | $108.7M | |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | $852.0K | -$48.0K | -$3.7M | $4.3M | -$549.0K | |
| Foreign Currency Transaction Gain Loss Realized After Tax | -$13.4M | $10.2M | $18.8M | $5.5M | -$3.2M | |
| Stock Issued During Period Value New Issues | $291.0M | $1.04B | $665.3M | $0.00 | $976.1M | $1.58B |
| Investment Company Voluntary Fee Waived | $0.00 | $0.00 | $15.6M | $13.9M | $2.3M | $0.00 |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $662.9M | $604.8M | $472.8M | $365.1M | $270.6M | $149.5M |
| Investment Company Contractual Fee Waived | $0.00 | $0.00 | $20.2M | $25.4M | $4.2M | $0.00 |
| Income Based Incentive Fee Expense | $150.1M | $134.2M | $97.2M | $67.3M | $42.0M | |
| Stock Issued1 | $23.0M | $21.1M | $20.7M | $52.4M | $38.9M | $18.7M |
| Paid In Kind Interest Noncash | $101.1M | $83.0M | $51.6M | $40.3M | $9.2M | $7.6M |
| Foreign Currency Transaction Gain Loss Unrealized | $852.0K | $567.0K | -$3.7M | $4.3M | -$549.0K | $11.0K |
| Excise Taxes Paid | $15.1M | $11.4M | $5.2M | $4.1M | $131.0K | $570.0K |
| Distribution Costs Incurred But Not Yet Paid | $178.6M | $170.8M | $143.1M | $96.2M | $89.7M | $86.6M |
| Capital Gains Incentive Fee Expense | $0.00 | -$5.5M | -$11.9M | $16.3M | ||
| Investment Percentage Of Portfolio Above Floor Rate | 88.1% | 89.4% | 93.7% | 93.1% | 93.9% | |
| Investment Owned At Fair Value | $14.21B | $13.09B | $9.87B | $9.62B | $9.86B | |
| Investment Owned At Cost | $14.39B | $13.19B | $9.93B | $9.66B | $9.75B | |
| Additional Paid In Capital | $6.05B | $5.75B | $4.70B | $4.03B | $4.25B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $5.5M | $5.4M | $5.1M | $5.1M | $5.3M | $5.6M | $4.6M | $5.4M | $5.1M | $11.5M | $16.5M | $11.5M | $9.1M |
| Trustee Fees | $282.0K | $293.0K | $306.0K | $286.0K | $289.0K | $222.0K | $222.0K | $236.0K | $225.0K | $238.0K | $209.0K | $181.0K | $141.0K |
| Professional Fees | $1.4M | $1.2M | $886.0K | $1.3M | $1.1M | $951.0K | $1.8M | $1.0M | $1.2M | $762.0K | $1.1M | $707.0K | $939.0K |
| Net Investment Income | $193.7M | $179.7M | $193.0M | $189.8M | $176.5M | $169.2M | $165.8M | $176.5M | $151.8M | $132.1M | $105.3M | $104.1M | $96.0M |
| Management Fee Expense | $35.0M | $34.6M | $34.3M | $30.2M | $28.1M | $26.0M | $24.2M | $24.3M | $24.7M | $25.4M | $25.9M | $25.6M | $15.4M |
| Investment Income Operating Tax Expense Benefit | $4.2M | $3.8M | $4.2M | $3.9M | $3.4M | $3.4M | $5.0M | $5.0M | $2.6M | $0.00 | $0.00 | $1.4M | $2.2M |
| Investment Income Operating After Expense And Tax | $189.5M | $175.9M | $188.8M | $185.9M | $173.1M | $165.8M | $160.8M | $171.5M | $149.2M | $132.1M | $105.3M | $102.7M | $93.8M |
| Investment Income Investment Expense | $164.9M | $165.1M | $164.8M | $153.4M | $150.5M | $134.8M | $129.0M | $124.9M | $123.7M | $104.7M | $91.2M | $91.0M | $70.8M |
| Investment Company Dividend Distribution | $177.8M | $177.0M | $175.4M | $160.9M | $152.7M | $147.7M | $133.6M | $115.8M | $112.4M | $130.1M | $123.2M | $132.3M | $74.0M |
| Gross Investment Income Operating | $358.6M | $344.8M | $357.8M | $343.2M | $327.1M | $304.0M | $284.0M | $290.4M | $264.9M | $226.8M | $187.0M | $185.6M | $166.9M |
| Administrative Fees Expense | $766.0K | $744.0K | $966.0K | $525.0K | $765.0K | $677.0K | $544.0K | $675.0K | $378.0K | $687.0K | $349.0K | $840.0K | $500.0K |
| Interest Paid Net | $113.5M | $68.9M | $96.3M | $104.1M | $61.0M | $72.6M | $79.6M | $37.5M | $88.5M | $69.9M | $14.9M | $61.4M | |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$36.3M | -$11.3M | -$43.9M | -$19.1M | $21.1M | $11.8M | $20.7M | -$37.5M | -$14.5M | -$70.6M | -$28.0M | -$1.4M | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$20.7M | -$9.6M | $4.9M | -$15.1M | $2.0M | $6.1M | -$10.5M | $10.9M | $4.2M | $34.4M | $2.3M | $5.9M | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$57.0M | -$20.9M | -$39.0M | -$34.2M | $23.1M | $17.9M | $10.2M | -$26.6M | -$10.4M | -$36.2M | -$25.7M | $4.5M | |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | $405.0K | $438.0K | $282.0K | -$2.3M | $124.0K | -$21.0K | -$133.0K | -$223.0K | -$3.1M | $64.0K | -$333.0K | $735.0K | |
| Foreign Currency Transaction Gain Loss Realized After Tax | -$11.6M | -$541.0K | -$987.0K | $2.2M | $1.8M | $5.7M | -$1.5M | $11.7M | $7.7M | $3.1M | -$176.0K | $567.0K | |
| Stock Issued During Period Value New Issues | $21.2M | $64.0M | $184.8M | $310.3M | $190.1M | $162.0M | $210.2M | $124.9M | $0.00 | $0.00 | $356.3M | ||
| Investment Company Voluntary Fee Waived | $0.00 | $0.00 | $0.00 | $4.8M | $4.9M | $4.3M | $3.7M | $3.0M | $3.0M | $0.00 | |||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $153.4M | $150.5M | $134.8M | $118.2M | $113.9M | $113.1M | $94.6M | $81.7M | $81.5M | $70.8M | |||
| Investment Company Contractual Fee Waived | $0.00 | $0.00 | $0.00 | $6.1M | $6.1M | $6.2M | $6.3M | $6.5M | $6.4M | $0.00 | |||
| Income Based Incentive Fee Expense | $34.3M | $38.2M | $37.4M | $35.8M | $33.4M | $34.5M | $30.4M | $26.1M | $20.9M | $21.3M | $17.0M | ||
| Stock Issued1 | $5.1M | $5.6M | $5.1M | $11.5M | |||||||||
| Paid In Kind Interest Noncash | $22.6M | $20.0M | $12.4M | $10.7M | |||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $282.0K | -$21.0K | -$3.1M | $735.0K | |||||||||
| Excise Taxes Paid | $15.1M | $11.4M | $5.2M | $4.1M | |||||||||
| Distribution Costs Incurred But Not Yet Paid | $175.4M | $147.7M | $112.4M | $132.3M | |||||||||
| Capital Gains Incentive Fee Expense | $0.00 | -$6.0M | $3.1M | $3.1M | $1.5M | -$3.9M | -$1.6M | -$5.4M | -$3.9M | $681.0K | $2.4M | ||
| Investment Percentage Of Portfolio Above Floor Rate | 88.4% | 89.8% | 89.5% | 90.6% | 92.5% | 92.9% | 94.0% | 93.8% | 94.1% | 94.3% | |||
| Investment Owned At Fair Value | $13.81B | $13.25B | $12.83B | $11.98B | $11.29B | $10.44B | $9.50B | $9.29B | $9.63B | $9.67B | |||
| Investment Owned At Cost | $13.93B | $13.33B | $12.95B | $12.01B | $11.33B | $10.50B | $9.55B | $9.35B | $9.67B | $9.71B | |||
| Additional Paid In Capital | $6.04B | $6.01B | $5.94B | $5.38B | $5.06B | $4.87B | $4.38B | $4.17B | $4.04B | $4.07B |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 10, 2026.